This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ungar, B L Articles by Finkelman, F D Search for Related Content PubMed PubMed Citation Articles by Ungar, B L Articles by Finkelman, F D

 Previous Article  |  Next Article 

Infect Immun. 1990 April; 58(4): 961-969

New mouse models for chronic Cryptosporidium infection in immunodeficient hosts.

Department of Preventive Medicine, Uniformed Services, University of the Health Sciences, Bethesda, Maryland 20814-4799.

ABSTRACT

Cryptosporidium sp. causes fulminant diarrhea and chronic infection in immunocompromised, particularly human immunodeficiency virus-infected, persons. The lack of in vitro cultivation and a suitable animal model has limited development of effective treatment. We describe two new mouse models of chronic symptomatic cryptosporidiosis in adult athymic mice and in T-cell subset-depleted mice. A progressive infection, fatal within 4 months, occurred in most adult athymic mice; a few developed stable infections. Symptoms included dehydration, weight loss, intermittent diarrhea, and jaundice. Pathologic abnormalities and organisms localized in the intestine in stable infections but involved the hepatobiliary tree and pancreas in others. Lymphoid cells from histocompatible, Cryptosporidium sp.-immune mice cured infected nude mice. Identical infections occurred in neonatally infected BALB/c mice treated with anti-CD4 monoclonal antibodies alone or also with anti-CD8 monoclonal antibodies; the mice were cured when the monoclonal antibody treatments were stopped. These models will be useful in definition of the immune defects that permit chronic cryptosporidiosis to develop and in assessment of treatment modalities.

This article has been cited by other articles:

• Pantenburg, B., Dann, S. M., Wang, H.-C., Robinson, P., Castellanos-Gonzalez, A., Lewis, D. E., White, A. C. Jr. (2008). Intestinal Immune Response to Human Cryptosporidium sp. Infection. Infect. Immun. 76: 23-29 [Full Text]  
• Lacroix-Lamande, S., Mancassola, R., Naciri, M., Laurent, F. (2002). Role of Gamma Interferon in Chemokine Expression in the Ileum of Mice and in a Murine Intestinal Epithelial Cell Line after Cryptosporidium parvum Infection. Infect. Immun. 70: 2090-2099 [Abstract] [Full Text]  
• Leitch, G. J., He, Q. (1999). Reactive Nitrogen and Oxygen Species Ameliorate Experimental Cryptosporidiosis in the Neonatal BALB/c Mouse Model. Infect. Immun. 67: 5885-5891 [Abstract] [Full Text]  
• Adjei, A. A., Jones, J. T., Riggs, M. W., Enriquez, F. J. (1999). Evidence of Thymus-Independent Local and Systemic Antibody Responses to Cryptosporidium parvum Infection in Nude Mice. Infect. Immun. 67: 3947-3951 [Abstract] [Full Text]  
• Cosyns, M., Tsirkin, S., Jones, M., Flavell, R., Kikutani, H., Hayward, A. R. (1998). Requirement for CD40-CD40 Ligand Interaction for Elimination of Cryptosporidium parvum from Mice. Infect. Immun. 66: 603-607 [Abstract] [Full Text]